HMG20B anticorps (AA 31-50)
Aperçu rapide pour HMG20B anticorps (AA 31-50) (ABIN636227)
Antigène
Voir toutes HMG20B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 31-50
-
Réactivité croisée (Details)
- This antibodys immunogens shares 80 % sequence identity with its Mouse homolog.
-
Purification
- Affinity chromatography purified
-
Immunogène
- BRAF35 antibody was raised in rabbit using AA 31-50 [KQERGEGPRA GEKGSHEEEP] of the human structural DNA-binding protein BRAF35 as the immunogen.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
Autre désignation
- BRAF35
-
Sujet
- Mutations of the human BRCA2 gene confer susceptibility to breast cancer. A structural DNA binding component has been identified and is designated as BRCA2-Associated Factor 35 (BRAF35). There is a close association of the BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Experimental evidence suggests a role for the BRCA2/BRAF35 complex in the modulation of cell cycle progression.
Antigène
-